C92.A1
Acute myeloid leukemia with multilineage dysplasia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code C92.A1 refers to a specific type of blood cancer known as acute myeloid leukemia (AML) with multilineage dysplasia, currently in remission. This condition involves abnormal development of blood cells in the bone marrow, which can interfere with normal blood function. Being in remission indicates that the signs and symptoms of leukemia are not currently active, although ongoing monitoring and treatment are typically needed to manage the condition.
Causes & Symptoms
Clinical Causes: Genetic mutations within hematopoietic stem cells Exposure to chemotherapy or radiation therapy Previous history of other blood disorders Environmental factors such as exposure to carcinogens (e.g., benzene, chemicals) Inherited genetic conditions Age-related genetic changes
Key Symptoms: Fatigue and weakness Unexplained fever or night sweats Frequent or severe infections Easy bruising or bleeding, such as nosebleeds or bleeding gums Pale skin due to anemia Bone or joint pain Swollen lymph nodes or spleen Unintended weight loss
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to detect abnormal levels of blood cells Bone marrow biopsy to examine the marrow for dysplastic blood cell production Cytogenetic analysis and molecular testing to identify genetic mutations Flow cytometry to determine cell types and characteristics Imaging tests such as ultrasound or CT scans if organ involvement is suspected
Treatment Protocols: Supportive care like blood transfusions and antibiotics to prevent or treat infections Chemotherapy to eliminate remaining leukemia cells and prevent relapse Targeted therapies focusing on specific genetic mutations Stem cell or bone marrow transplantation for eligible patients Regular monitoring through blood tests and bone marrow evaluations to detect any signs of recurrence
Clinical Advice & FAQs
Billing Guidance
Is C92.A1 a billable ICD-10 code?
Yes, C92.A1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.A1?
Clinical documentation must specify the nature of Acute myeloid leukemia with multilineage dysplasia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference